MAM
BCYC

Meeder Asset Management’s Bicycle Therapeutics BCYC Stock Holding History

Meeder Asset Management’s Portfolio BCYC Stock Details BCYC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-2
Closed – – 908
2022
Q3 		$0 Hold
2
– – ﹤0.01% 2151
2022
Q2 		$0 Hold
2
– – ﹤0.01% 2179
2022
Q1 		$0 Buy
+2
New +$93 ﹤0.01% 2328

Other funds holding BCYC

DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
RCI
Ridgeback Capital Investments Miami Beach, Florida $560K AUM
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
SC
Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return
TCM
Tybourne Capital Management Hong Kong $30.9M AUM 20.1% 1-Year Est. Return

Meeder Asset Management's BCYC Position: Q4 2022 in Review

Meeder Asset Management sold out of Bicycle Therapeutics (BCYC) in Q4 2022, closing a stake of 2 shares.

Meeder Asset Management first reported a position in BCYC in Q1 2022 and held it in 3 quarters. The position peaked at $0 in Q3 2022. 87 funds tracked by Wall St. Rank hold BCYC as of Q4 2022.

  • Meeder Asset Management reported no remaining Bicycle Therapeutics position as of Q4 2022 after selling out during the quarter.
  • Meeder Asset Management sold 2 Bicycle Therapeutics shares in Q4 2022.
  • Meeder Asset Management first reported a position in Bicycle Therapeutics in Q1 2022 and held it in 3 quarters.
  • Meeder Asset Management's Bicycle Therapeutics position peaked at $0 in Q3 2022.
  • 87 funds tracked by Wall St. Rank held Bicycle Therapeutics as of Q4 2022.

Based on Meeder Asset Management's 13F filing for Q4 2022, filed 14 Feb 2023.